Tigecycline Injection, Powder, Lyophilized, For Solution
Product Images NDC 55150-228

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tigecycline (NDC 55150-228). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (50 mg per vial)

Package Label-principal Display Panel (50 mg per vial)
Tigecycline is an intravenous antibiotic medication used to treat certain bacterial infections. Each vial contains 50 mg of tigecycline and 100 mg of lactose. The solution after reconstitution should be yellow to orange in color. The medication is distributed by AuroMedics Pharma LLC and is manufactured in India. This medication requires a prescription and should only be administered intravenously.*
FDA Label Image

Package Label-principal Display Panel (50 mg per vial)

Package Label-principal Display Panel (50 mg per vial)
The text is not readable and appears to be a mix of random characters and symbols.*
FDA Label Image

Tigecycline Chemical Structure (Tigecycline Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.